Literature DB >> 1864975

Acute lung injury. Pathogenesis of intraalveolar fibrosis.

L S Snyder1, M I Hertz, M S Peterson, K R Harmon, W A Marinelli, C A Henke, J R Greenheck, B Chen, P B Bitterman.   

Abstract

In patients dying with acute lung injury, interstitial mesenchymal cells migrate into the airspace where they replicate and deposit connective tissue. We therefore hypothesized that peptides capable of promoting mesenchymal cell migration and replication would be present in the alveolar airspace. To examine this hypothesis, patients with severe acute diffuse lung injury (n = 26) underwent bronchoalveolar lavage. Acutely ill patients without lung injury served as controls (n = 12). Recovered effluent was examined for mesenchymal cell growth-promoting and migration-promoting activity. Lavage cell supernates from both patients and controls were devoid of bioactivity. However, substantial growth-promoting and migration-promoting activity was present in lavage fluid from nearly every patient, whereas little or none was present in fluid from controls. Characterization of the bioactivity indicated a significant proportion consisted of three peptides related to PDGF: (a) a 14-kD peptide that shared with PDGF several biophysical, biochemical, receptor-binding, and antigenic properties; (b) a 29-kD peptide that appeared identical to PDGF of platelet origin; and (c) a 38-kD peptide that was biophysically and antigenically similar to PDGF. These data indicate that peptide moieties are present in the airspace of patients after acute lung injury that can signal mesenchymal cell migration and replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864975      PMCID: PMC295409          DOI: 10.1172/JCI115351

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity.

Authors:  Y Martinet; P B Bitterman; J F Mornex; G R Grotendorst; G R Martin; R G Crystal
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  Dermal fibroblasts.

Authors:  R G Ham
Journal:  Methods Cell Biol       Date:  1980       Impact factor: 1.441

3.  Plasma binding proteins for platelet-derived growth factor that inhibit its binding to cell-surface receptors.

Authors:  E W Raines; D F Bowen-Pope; R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Purification of human platelet-derived growth factor.

Authors:  E W Raines; R Ross
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Cultured endothelial cells produce multiple growth factors for connective tissue cells.

Authors:  P E DiCorleto
Journal:  Exp Cell Res       Date:  1984-07       Impact factor: 3.905

6.  Specific covalent binding of platelet-derived growth factor to human plasma alpha 2-macroglobulin.

Authors:  J S Huang; S S Huang; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

8.  Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor.

Authors:  K C Robbins; H N Antoniades; S G Devare; M W Hunkapiller; S A Aaronson
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

9.  Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis.

Authors:  T Collins; D Ginsburg; J M Boss; S H Orkin; J S Pober
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

10.  Studies on the pathogenesis of the adult respiratory distress syndrome.

Authors:  W W McGuire; R G Spragg; A B Cohen; C G Cochrane
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

View more
  23 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 2.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

3.  A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.

Authors:  Koichiro Suemori; Hiroshi Fujiwara; Seiichiro Watanabe; Taichi Azuma; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2010-11-26       Impact factor: 2.490

Review 4.  Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease.

Authors:  K A Nath
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Role of mesenchymal cell death in lung remodeling after injury.

Authors:  V A Polunovsky; B Chen; C Henke; D Snover; C Wendt; D H Ingbar; P B Bitterman
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 7.  The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.

Authors:  Ellen L Burnham; William J Janssen; David W H Riches; Marc Moss; Gregory P Downey
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

8.  Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury.

Authors:  C Henke; W Marineili; J Jessurun; J Fox; D Harms; M Peterson; L Chiang; P Doran
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

9.  Prostaglandin E2 mediates IL-1beta-related fibroblast mitogenic effects in acute lung injury through differential utilization of prostanoid receptors.

Authors:  Kimberly E White; Qiang Ding; Bethany B Moore; Marc Peters-Golden; Lorraine B Ware; Michael A Matthay; Mitchell A Olman
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

10.  Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype.

Authors:  B Chen; V Polunovsky; J White; B Blazar; R Nakhleh; J Jessurun; M Peterson; P Bitterman
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.